Archive for November 2012

[vc_row][vc_column][vc_column_text]Framingham, MA, September 27, 2012 – Dilon Devices announced today that the MarginProbe System will be used at the Agaplesion Markus Hospital, in Frankfurt, Germany.  The Agaplesion Markus Hospital is the largest breast center in the Frankfurt area, treating over 400 primary breast cancer cases annually. “In my previous work with the MarginProbe System, we…

[vc_row][vc_column][vc_column_text]Framingham, Mass., November 19, 2012 – Dilon Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration.   The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval…